Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI), most recent 12 months reported: revenue $1.31M, net loss $8.31M, free cash flow -$6.05M. Latest balance sheet on file: liquid cash $1.66M, total debt $294K, net cash $1.37M. From SEC filings. More on SCINAI IMMUNOTHERAPEUTICS LTD.: Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): DYADIC INTERNATIONAL INC · Aligos Therapeutics, Inc. · Humacyte, Inc. · OUTLOOK THERAPEUTICS, INC. · INHIBRX BIOSCIENCES, INC. · Pluri Inc. · ProKidney Corp. · ImageneBio, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.